(Q64189689)
Statements
An Open-label Non-randomized, Phase 1 Single Dose Study to Evaluate the Pharmacokinetics and Safety of Copanlisib in Subjects With Impaired Hepatic or Renal Function in Comparison to Healthy Subjects (English)
0 references
14 June 2017
0 references
12 July 2019
0 references
44
0 references
18 year
0 references
80 year
0 references